← Back to catalogue

TriMAX Implant System

FDA UDI

Class II (US FDA UDI)

by Crossroads Extremity Systems Llc

Identity

Trade Name
TriMAX Implant System FDA UDI
Generic Name
Intraoperative bone pin/screw, non-sterile FDA UDI
Device Name
The TriMAX Impant System is a Nitinol Superelastic bone staple for use in surgery of the hand and foot for bone fragment osteotomy fixation and joint arthrodesis. FDA UDI
Model / Reference
TriMAX 25mm Full Prep Kit FDA UDI
Description
The TriMAX Impant System is a Nitinol Superelastic bone staple for use in surgery of the hand and foot for bone fragment osteotomy fixation and joint arthrodesis. FDA UDI

Identifiers

Catalog Number
7300-2500KT FDA UDI
Primary DI / UDI-DI
00815432027613 FDA UDI
FDA Product Code
JDR FDA UDI
GMDN Term
Intraoperative bone pin/screw, non-sterile FDA UDI

Classification

Device Class
Class II FDA UDI
Regulation Number
888.3030 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

Yes

FDA UDI

Single Use

Yes

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

Yes

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Category: Surgical drill guide, reusableOrthopaedic inorganic implant inserter/extractor, reusableOrthopaedic implant impactor, reusableOrthopaedic broach

TriMAX Implant System by Crossroads Extremity Systems Llc — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Bone-resection orthopaedic reamer, reprocessed.

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (1)

  • FDA UDI 486c1569-9495-48b0-94b3-4ff3366e09b8 35 fields · synced May 30, 2026